Vasculogenic mimicry is associated with trastuzumab resistance of HER2-positive breast cancer

BACKGROUND: Trastuzumab is a drug that targets the receptor tyrosine kinase HER2 and is essential for the treatment of HER2-positive breast cancer. Resistance to the drug leads to severe consequences, including disease recurrence, tumor enlargement, and metastasis. We hypothesized that trastuzumab t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res
Main Authors: Hori, Ami, Shimoda, Masafumi, Naoi, Yasuto, Kagara, Naofumi, Tanei, Tomonori, Miyake, Tomohiro, Shimazu, Kenzo, Kim, Seung Jin, Noguchi, Shinzaburo
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6683360/
https://ncbi.nlm.nih.gov/pubmed/31387614
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-019-1167-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados